Physician

Adam Charles Tzagournis, MD

According to 2025 Medicare claims, Adam Tzagournis, MD (NPI: 1003863440) practices gastroenterology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is DIGESTIVE ASSOCIATES OF OHIO (NPI: 1528383346; TIN: 272176440) and primary practice location at 43215-3946. Tzagournis is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Tzagournis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 369 traditional Medicare patients, billed 864 HCPCS/CPT codes, and received $64,646 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,391 prescription claims across 460 beneficiaries totaling $964,232 in drug costs, led by Stelara (Ustekinumab). 2020 DME data shows 24 claims. Open Payments data shows 153 records totaling $3,281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $101,067 to $64,646. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $351,859 to $964,232. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	516	964	$101,067
2016	589	1,014	$100,118
2017	650	1,254	$108,772
2018	549	1,126	$95,117
2019	514	1,116	$97,054
2020	470	1,023	$81,631
2021	445	941	$74,663
2022	331	766	$57,744
2023	360	874	$62,360
2024	369	864	$64,646

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	548	1,709	$351,859
2016	293	1,265	$341,840
2017	280	1,110	$571,574
2018	276	1,020	$595,411
2019	294	1,138	$764,821
2020	320	1,352	$864,938
2021	391	1,507	$1,111,805
2022	409	1,416	$952,483
2023	406	1,422	$969,212
2024	460	1,391	$964,232

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$2,187
2019	N/R	24	$2,150
2020	N/R	24	$2,224
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	89	90	$192
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	84	84	$97
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	89	94	$76
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	71	96	$56
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	166	179	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	19	1,038	$508,001
Xifaxan	Rifaximin	31	578	$81,437
Linzess	Linaclotide	44	3,450	$62,042
Viberzi	Eluxadoline	22	1,020	$53,556
Trulance	Plecanatide	29	2,010	$37,485

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	153	$3,281	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Charles Tzagournis, MD?

Tedicare shows public-source Medicare data for Adam Charles Tzagournis, MD (NPI 1003863440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Charles Tzagournis, MD have ACO affiliation data?

Adam Charles Tzagournis, MD is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Adam Charles Tzagournis, MD?

Adam Charles Tzagournis, MD is linked to DIGESTIVE ASSOCIATES OF OHIO (billing NPI 1528383346) in the available physician profile data.

Does Adam Charles Tzagournis, MD have Open Payments data?

Adam Charles Tzagournis, MD has 153 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.